Discover 317 paid clinical trials in Albuquerque, New Mexico. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 317
Active & Responsive
Enhancing Veteran-Clinical Collaboration in VA PRRCs
Location: Albuquerque NM, Amarillo TX, Scottsdale AZ, Abilene TX,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07440225
Phase 2, Phase 3, Recruiting
Active & Responsive
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Albuquerque NM, Houston TX, Santa Rosa CA,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
for
Kidney Disease
Location: Albuquerque NM, El Paso TX, Surprise AZ,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06963827
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
for
Hyperphosphatemia,
Location: Albuquerque NM, Denver CO, Las Vegas NV, Waxahachie TX,
Sponsor: R1 Therapeutics
Sex: All
Age: 18+
Code: NCT06712654
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Albuquerque NM, El Paso TX, Chandler AZ, Las Vegas NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
for
Prostate Cancer,
Location: Albuquerque NM, San Diego CA, New Orleans LA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: Male
Age: 18+
Code: NCT07005154
Phase 2, Recruiting
Active & Responsive
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
for
Phantom Limb Syndrome With Pain
Location: Albuquerque NM, Santa Monica CA, Sacramento CA,
Sponsor: The Ketamine Research Foundation
Sex: All
Age: 18 - 65
Code: NCT07276542
Phase 2, Phase 3, Recruiting
Active & Responsive
RA-PRO PRAGMATIC TRIAL
for
Rheumatoid Arthritis
Location: Santa Fe NM, Clovis NM, El Paso TX, Tucson AZ,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04692493
Phase 3, Recruiting
Active & Responsive
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
for
HIV-1-infection
Location: Sante Fe NM, El Paso TX, Denver CO, Salt Lake City UT,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07645287
Phase 2, Recruiting
Active & Responsive
Caris Biorepository Research Protocol
for
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Santa Fe NM, Amarillo TX, Scottsdale AZ, Texarkana TX,
Sponsor: Caris Science, Inc.
Sex: All
Age: 18+
Code: NCT01499394
Recruiting
Active & Responsive
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Santa Fe NM, Irvine CA, Duarte CA, Houston TX,
Sponsor: Xerient Pharma
Sex: All
Age: 18+
Code: NCT07157033
Phase 1, Phase 2, Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Santa Fe NM, Phoenix AZ, Denver CO, Cheyenne WY,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV
Location: Santa Fe NM, El Paso TX, Phoenix AZ, Las Vegas NV,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
for
Asthma
Location: Albuquerque NM, San Diego CA, Tomball TX, Houston TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12 - 70+
Code: NCT07782996
Phase 3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Albuquerque NM, Durango CO, Pueblo CO,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase 3, Recruiting
Psilocybin for Opioid Use Disorder (OUD)
for
Opioid Use Disorder
Location: Albuquerque NM, New York NY, Brooklyn NY, The Bronx NY
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 65
Code: NCT06796062
Phase 2, Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Albuquerque NM, Amarillo TX, Goodyear AZ, Las Vegas NV,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06423911
Phase 3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations